7
Copy right t 9144 b The Journal of Bot .a, id Joint .Surgert . It corp()r(It. VOL 66-A, NO. I . JANUARY 954 53 Dedifferentiated Parosteal Osteosarcoma BY LESTER E. WOLD, M.D.*, KRISHNAN K. UNNI, M.D.*, JOHN W. BEABOUT, M.D.*, FRANKLIN H. SIM, M.D.*. AND DAVID C. DAHLIN, M.D.*, ROCHESTER, MINNESOTA From the Section of Surgical Pathology and the Departments of Diagnostic Radiology and Orthopedics. Maw Clinic and Mayo Foundation, Rochester ABSTRACT: Parosteal osteosarcoma is an uncom- mon malignant tumor of bone, and in a review of Mayo Clinic records we identified eleven cases of so-called de- differentiated parosteal osteosarcoma. Ten of the eleven patients had had a long history of treatment for multiple recurrences of the tumor as a low-grade parosteal os- teosarcoina and then for a definite recurrence as a high- grade undifferentiated osteosarcoma. The prognosis in this group of patients was similar to that in patients with conventional osteosarcoma. Parosteal osteosarcoma was first described as a distinct clinicopathological entity in 195 1 , but it was called parosteal osteoma8. Since that time, there has been a general con- sensus in the literature that the tumor is of low-grade ma- lignancy, as pointed out in reports of several small series72. Although most of the parosteal osteosarcomas described in the present report were found by a review of the records of tumors occurring on the surface of bone - that is, tumors that lack medullary involvement - not all of the surface lesions in our series were low-grade parosteal osteosarcoma. A variety of other tumors develop on the surface of bone, including periosteal chondroma , periosteal osteosarcoma, and various surface tumors that extend into the medullary areas of bone and have the histological appearance of either intramedullary osteosarcoma or osteochondroma . Even such reactive conditions as ossifying or calcifying hematomas can occur on the surface of bone and extend toward the marrow. Previous studies of parosteal, or juxtacortical, tumors have included mention of the occasional occurrence of high- grade anaplastic tumors that do not fit the usual patterns that are associated with parosteal osteosarcoma579’#{176}’24. In most of these reports a low-grade parosteal osteosarcoma ‘dedifferentiated’ , after multiple recurrences, to high- grade tumor. In 1979, Dunham et al. reported on a patient with a large parosteal osteosarcoma that had ‘transformed” into a high-grade osteosarcoma. This had previously been reported from the Mayo Clinic; such a so-called transfor- mation had been noted in three of fifteen5 and seven of I 2 patients with parosteal osteosarcoma. The present series consisted of eleven Mayo Clinic * Mayo Clinic. 200 First Street SW. , Rochester. Minnesota 55905. Please address reprint requests to Dr. Wold. patients in whom dedifferentiation of parosteal osteosar- coma was evident. We undertook this study to define the clinical and prognostic correlates of histologically high- grade malignant tumors that coexist with or are derived from the usual low-grade parosteal osteosarcoma. Clinical Observations We identified eleven cases ofdedifferentiated parosteal osteosarcoma in fifty-five patients who were treated at the Mayo Clinic for parosteal osteosarcoma. These eleven pa- tients comprised perhaps 1 per cent of the approximately 1 ,200 patients who were seen with osteosarcoma. Gross specimens of the high-grade recurrence were available for review for six of the eleven patients. and multiple histo- logical sections were available for review for all patients (including sections of the original tumor in five of them). When necessary, additional histological material was sub- milled for evaluation, in particular to document the presence or absence of evidence of medullary involvement. Clinical data and follow-up information were obtained from the pa- tients’ charts and from letters from the referring physicians. There were seven female and four male patients. At the time of the onset of symptoms or at the first attempt at therapy, six were in their teen-age years. three were in their twenties, and two were in their thirties. The initial symptoms were those most commonly associated with neoplasia of bone - that is, pain or a mass, or both. The distribution of these tumors was equivalent to that associated with or- dinary low-grade parosteal osteosarcoma: eight tumors were in the distal part of the femur: two, in the proximal part of the humerus; and one, in the proximal part of the tibia. Of the eleven patients, one had coexistent low-grade parosteal osteosarcoma and high-grade dedifferentiation when first seen. Dedifferentiation was documented in three patients at the time of the first recurrence. in five at the time of the second, and in two at the time of the third recurrence. The interval from the onset of symptoms or the tinie of the first operation to the time of dedifferentiation ranged from thirty-one to 396 months, with a mean of I 53 months (Table I). At the time of dedifferentiation. six patients had a minimum amount (less than one centimeter) of medullary involvement. Radiographs or photographic copies of radiographs were available for seven of the eleven patients. Interpre-

wiri

Embed Size (px)

DESCRIPTION

wiriawan

Citation preview

  • Copy right t 9144 b The Journal of Bot .a, id Joint .Surgert . It corp()r(It.

    VOL 66-A, NO. I . JANUARY 954 53

    Dedifferentiated Parosteal Osteosarcoma

    BY LESTER E. WOLD, M.D.*, KRISHNAN K. UNNI, M.D.*, JOHN W. BEABOUT, M.D.*, FRANKLIN H. SIM, M.D.*.

    AND DAVID C. DAHLIN, M.D.*, ROCHESTER, MINNESOTA

    From the Section of Surgical Pathology and the Departments of Diagnostic Radiology and Orthopedics.

    Maw Clinic and Mayo Foundation, Rochester

    ABSTRACT: Parosteal osteosarcoma is an uncom-

    mon malignant tumor of bone, and in a review of Mayo

    Clinic records we identified eleven cases of so-called de-

    differentiated parosteal osteosarcoma. Ten of the eleven

    patients had had a long history of treatment for multiple

    recurrences of the tumor as a low-grade parosteal os-

    teosarcoina and then for a definite recurrence as a high-

    grade undifferentiated osteosarcoma. The prognosis in

    this group of patients was similar to that in patients with

    conventional osteosarcoma.

    Parosteal osteosarcoma was first described as a distinct

    clinicopathological entity in 195 1 , but it was called parosteal

    osteoma8. Since that time, there has been a general con-

    sensus in the literature that the tumor is of low-grade ma-

    lignancy, as pointed out in reports of several small series72.

    Although most of the parosteal osteosarcomas described in

    the present report were found by a review of the records of

    tumors occurring on the surface of bone - that is, tumors

    that lack medullary involvement - not all of the surface

    lesions in our series were low-grade parosteal osteosarcoma.

    A variety of other tumors develop on the surface of bone,

    including periosteal chondroma , periosteal osteosarcoma,

    and various surface tumors that extend into the medullary

    areas of bone and have the histological appearance of either

    intramedullary osteosarcoma or osteochondroma . Even such

    reactive conditions as ossifying or calcifying hematomas

    can occur on the surface of bone and extend toward the

    marrow.

    Previous studies of parosteal, or juxtacortical, tumors

    have included mention of the occasional occurrence of high-

    grade anaplastic tumors that do not fit the usual patterns that

    are associated with parosteal osteosarcoma579#{176}24. In

    most of these reports a low-grade parosteal osteosarcoma

    dedifferentiated , after multiple recurrences, to high-

    grade tumor. In 1979, Dunham et al. reported on a patient

    with a large parosteal osteosarcoma that had transformed

    into a high-grade osteosarcoma. This had previously been

    reported from the Mayo Clinic; such a so-called transfor-

    mation had been noted in three of fifteen5 and seven of

    I 2 patients with parosteal osteosarcoma.

    The present series consisted of eleven Mayo Clinic

    * Mayo Clinic. 200 First Street SW. , Rochester. Minnesota 55905.

    Please address reprint requests to Dr. Wold.

    patients in whom dedifferentiation of parosteal osteosar-

    coma was evident. We undertook this study to define the

    clinical and prognostic correlates of histologically high-

    grade malignant tumors that coexist with or are derived from

    the usual low-grade parosteal osteosarcoma.

    Clinical Observations

    We identified eleven cases ofdedifferentiated parosteal

    osteosarcoma in fifty-five patients who were treated at the

    Mayo Clinic for parosteal osteosarcoma. These eleven pa-

    tients comprised perhaps 1 per cent of the approximately

    1 ,200 patients who were seen with osteosarcoma. Gross

    specimens of the high-grade recurrence were available for

    review for six of the eleven patients. and multiple histo-

    logical sections were available for review for all patients

    (including sections of the original tumor in five of them).

    When necessary, additional histological material was sub-

    milled for evaluation, in particular to document the presence

    or absence of evidence of medullary involvement. Clinical

    data and follow-up information were obtained from the pa-

    tients charts and from letters from the referring physicians.

    There were seven female and four male patients. At

    the time of the onset of symptoms or at the first attempt at

    therapy, six were in their teen-age years. three were in their

    twenties, and two were in their thirties. The initial symptoms

    were those most commonly associated with neoplasia of

    bone - that is, pain or a mass, or both. The distribution

    of these tumors was equivalent to that associated with or-

    dinary low-grade parosteal osteosarcoma: eight tumors were

    in the distal part of the femur: two, in the proximal part of

    the humerus; and one, in the proximal part of the tibia. Of

    the eleven patients, one had coexistent low-grade parosteal

    osteosarcoma and high-grade dedifferentiation when first

    seen.

    Dedifferentiation was documented in three patients at

    the time of the first recurrence. in five at the time of the

    second, and in two at the time of the third recurrence.

    The interval from the onset of symptoms or the tinie

    of the first operation to the time of dedifferentiation ranged

    from thirty-one to 396 months, with a mean of I 53 months

    (Table I). At the time of dedifferentiation. six patients had

    a minimum amount (less than one centimeter) of medullary

    involvement.

    Radiographs or photographic copies of radiographs

    were available for seven of the eleven patients. Interpre-

  • Fio. 1-A FIG. 1-B

    54 L. E. WOLD, K. K. UNNI, J. W. BEABOUT, F. H. SIM, AND D. C. DAHLIN

    THE JOURNAL OF BONE AND JOINT SURGERY

    Figs. 1-A. I-B. and I-C: Dedifferentiated parosteal osteosarcoma in the distal part of the finiur.Fig. I-A: Preoperative radiograph showing a typical broad-based. heavily mineralized parosteal osteosarcoma with lobulation. The tubulation of the

    femur is altered.Fig. 1-B: Appearance one year after the tumor was shaved off the surface of the femur.

    tations of the radiographs were available for the remaining

    patients, and all indicated that the tumor was on the surface

    of the bone.

    Radiographs made before any surgical procedure had

    been performed were available for five patients. All of the

    tumors were located on the surface of the bone and had the

    typical characteristics of parosteal osteosarcoma. None had

    any evidence of medullary involvement. Serial radiographs

    showing the entire course of the tumor were available for

    two patients (Figs. 1-A, 1-B, and 1-C). In both of them the

    parosteal osteosarcoma was originally thought to be a benign

    tumor (Fig. 1-A). Follow-up radiographs showed postop-

    erative changes (Fig. 1 -B) and then a mass appeared on the

    surface of the bone or in the adjacent soft tissues (Fig.

    1-C) at the site ofthe previous operation. In all five patients

    for whom preoperative radiographs could be compared with

    radiographs made at the time ofdedifferentiation, the degree

    of mineralization of the tumor matrix was consistently less

    in the dedifferentiated tumor than it had been in the initial

    parosteal osteosarcoma.

    All patients except one (Case 1 1 ) had biopsy or excision

    as the initial treatment. At the time ofdedifferentiation, nine

    patients were treated with amputation; one. with disarticu-

    lation; and one. with forequarter amputation. In general,

    the gross appearance of the tumor at the time of dediffer-

    entiation was somewhat similar to that of a usual low-grade

    parosteal osteosarcoma (Fig. 2). The general characteristics

    included areas of dense hard tumor, a broad base, a bos-

    selated surface with or without a cartilage cap. and infiltra-

    tion of surrounding skeletal muscle. Areas that were proved

    histologically to be dedifferentiated were grossly softer. His-

    tologically these tumors often had areas of low-grade par-

    osteal osteosarcoma, characterized by parallel arrays of

    irregularly shaped osseous trabeculae with an intervening

    spindle-cell component (Fig. 3). Adjacent to these areas

    were anaplastic high-grade foci, often with spindle-cell dif-

    ferentiation and the fine lacelike osteoid of conventional

    high-grade intramedullary osteosarcoma (Fig. 4). These

    areas had less well formed, dense osteoid production than

    did the adjacent low-grade portions of the tumor. The an-

    aplasia within these foci was considered to be grade 3 or 4

    according to Broders method. Six of the tumors involved

    the medullary cavity at the time of dedifferentiation (Fig.

    5). In two patients the medullary component was minimum

    and in four there was gross medullary involvement.

    Follow-up information was available for nine of the

  • FIG. 1-C

    A tumor of the distal part of the femur that recurred twice in a twenty-three-year period. Although a large portion of the neoplasm is on the surfaceof the bone. this dedifferentiated parosteal osteosarcoma now also involves the medullary cavity. The patient died of pulmonary metastases three yearsafter amputation.

    DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA 55

    Three years and three months after operation. a poorly mineralized four-centimeter mass is seen on the surface of the bone. indicating a recurrenttumor.

    eleven patients. Five had died of the disease and four pa-

    tients were alive (Table I). Ofthe six patients with medullary

    involvement, three had died of the disease, two were alive

    and free of disease, and one could not be followed. Of the

    five patients without medullary involvement, two were alive

    and free of disease, two had died of the disease. and one

    could not be followed.

    Discussion

    The 20 per cent incidence of dedifferentiation of low-

    grade parosteal osteosarcomas in patients at the Mayo Clinic

    is evidence of the importance of correct diagnosis and treat-

    ment when the lesion is first seen. This incidence is higher

    than that reported in other series but this may be due to a

    selection bias at our institution. Seven of the patients in this

    study were referred to the Mayo Clinic at the time that

    dedifferentiation was documented. Three patients (Cases 1,

    2, and 3; Table I) who were treated initially at the Mayo

    Clinic were seen before parosteal osteosarcoma was rec-

    ognized as a clinicopathological entity. Inadequate initial

    surgical treatment thus allowed for recurrence and dedif-

    ferentiation. Parosteal osteosarcomas are generally low-

    grade malignant tumors at the onset but have a tendency to

    become more anaplastic with recurrence354. Although they

    may maintain a low-grade malignant potential, with each

    recurrence there is potential for dedifferentiation.

    One must have a high index of suspicion with regard

    to dedifferentiation because there may be no significant din-

    ical clues to distinguish a true recurrence of a parosteal

    osteosarcoma from a recurrence with dedifferentiation . On

    the other hand, rapid growth of a lesion or severe pain

    suggests dedifferentiation. Also, radiographic lyric defects

    within tumors that have the classic appearance of low-grade

    parosteal osteosarcoma may be helpful in identifying pa-

    tients with dedifferentiation. At the time of recurrence, the

    high-grade component of these tumors is the most important

    prognostic indicator.

    A similar risk of dedifferentiation has been noted for

  • FIG. 3

    56 1.. 1. WOI.D. K. K. UNNI, J. W. BEABOUT, F. H. SIM, AND D. C. DAHLIN

    THE JOURNAL OF BONE AND JOINT SURGERY

    TABLE

    ClINICAL

    Case

    Site of

    Lesion Sex. A.e

    ( Yr. I

    Initial Operation First Recurrence Second Recurrence

    Date Type Date Treatment Date Treatment

    I I)kt. piO (I

    femur

    Ni. lS 4 18 27 Excision I 1/8/28 Amputation

    2 Prox. part of

    humerus

    F. 3() 62835 Biopsy 9/4/35 Excision 10/29/35 Excision

    3 I)ist. part of

    fentum

    F. 14 4,547 Excision 9/18/48 Excision I 1/21/49 Disartic.

    4 I)ist. part of

    fetiwr

    NI. 2() 1971 Excisiont 1974 Amputation

    5 Prox. part of

    humerus

    M. 19 1945 Excision 1958 Subtotal

    removall

    2/78 Amputation

    6 1)1st. part of

    femur

    F. 3(1 1964 Excisioni I 1/1/78 Aniputation

    7 I)ist. part of

    fetitur

    F. I I 1971 Biopsy 1975 Excisions 8/17/81 Amputation

    S Dist. part of

    femur

    F. 24 1932 Excisionl 1934 Biopsyl 1936 Biopsyl

    9 1)1st. part of

    fermium

    F. 16 1956 Excision 1956 Excision 7/22/70 Amputation

    It) I)ist. part of

    femur

    F. 15 1927 Incomplete

    removall

    1933 Incomplete

    removaI

    1937 Amputation

    I I Prox. metaph.

    of tibia and

    NI. 28 4/29/81 Amputation

    fibula

    * At the onset of svmptonls or at the initial operation.

    . Symptoms preceded the first operation by nine years.

    1: Performed elsewhere.

    well dedifferentiated intra-osseous osteosarcoma; in the se-

    ries of Unni et al.5. three of eleven tumors that recurred

    had changed from a low-grade to a highly undifferentiated

    tumor.

    Because of the potential for dedifferentiation of these

    lesions, an aggressive surgical approach to the initial lesion

    is imperative. This has been emphasized by Enneking et

    al. , who indicated that the most important factors in the

    prognosis are the surgical stage of the lesion and the ade-

    quacy of the surgical procedure.

    .istn area of mesidual lots gmade parosteal osteosarcotita s ith parallel bone trabeculae and intervening hypercellular fibrous connective tissue (hematoxylinand eosin. X 2 It)).

  • FIG. 4

    DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA 57

    VOL. 66-A, NO. 1. JANUARY 1984

    DATA

    Third Recurrence MedullaryInvolvement

    Follow-upTime from

    Onset to

    Dedifferentiation

    (Mos.)

    Time from

    Dedifferentiation to

    Last Follow-up

    (Mos.)

    Date Treatment Date Condition

    No 9/13/30 Died 127 22

    9i24l Disartic. No 12843 Died 75 15

    Yes 10 1381 No evidence of disease 31 384

    No 12 1 1 8 1 No evidence of disease 36 84

    Yes 4:781 Died 396 36

    Yes 180

    No 120

    7646 Amputation Yes 5 52 Died 168 71

    Slight 220/80 No evidence of disease 168 120

    Slight I 1343 Died 228 72

    No 6 9:82 No evidence of disease 0 14

    In our series ten ofthe initial lesions would be classified

    as stage lB , according to the staging system of Enneking

    et al. , because they were of low grade and did not extend

    into the underlying marrow or penetrate the overlying mus-

    cle - that is, the lesion occupied the potential paraosseous

    space. In the remaining patient (Case 1 1 , Table I), who had

    areas of high-grade tumor when first seen, the lesion would

    be classified as stage hA.

    Awareness of the potential for dedifferentiation of a

    parosteal osteosarcoma should stimulate increased interest

    in initial control of the primary lesion by effective surgical

    treatment. In this series, all ten patients who had a parosteal

    osteosarcoma when they were first seen had a standard mar-

    ginal excision, as advocated by Enneking et al. For local

    A region adjacent to that shown in Fig. 3. Other areas of these tumors were histologically identical to conventional high-grade intramedullaryosteosarcoma (hematoxylin and eosin. x 825).

  • FIG. 5

    58 L. E. WOLD. K. K. UNNI, J. W. BEABOUT, F. H. SIM, AND D. C. DAHLIN

    THE JOURNAL OF BONE AND JOINT SURGERY

    Permeation of the medullary cavity b a residual low-grade osteosarcoma. Note that the pre-existing benign bone trabeculae are broader than thethin intervening neoplastic trabeculae (hematoxylin and eosin. x 80).

    control of the tumor and prevention of recurrence with po-

    tential dedifferentiation, our current approach is wide local

    resection to obtain a wide surgical margin that includes an

    envelope of surrounding normal tissue. Unfortunately, if

    the parosteal lesion dedifferentiates into a stage-Il lesion -

    that is, a tumor with extracompartmental extension - the

    potential for a successful limb-salvage procedure is lost.

    Few of these tumors are small enough to be treated ade-

    quately with resection, and treatment for dedifferentiated

    parosteal osteosarcoma is similar to that for conventional

    high-grade osteosarcoma and generally involves amputa-

    tion.

    Although the incidence of dedifferentiation to high-

    grade osteosarcoma in patients with recurrent parosteal os-

    teosarcoma is significant, recognition of the coexistence of

    low-grade and high-grade tumor is rare when a patient is

    first seen. Such coexistence was seen in only one patient in

    this series. This emphasizes the necessity of adequate sam-

    pling of a parosteal osteosarcoma initially to be certain that

    dedifferentiation has not already occurred. In this series, in

    which many of the patients were treated elsewhere before

    being referred to the Mayo Clinic, one must question

    whether the initial sampling of the tumor was adequate to

    rule out the possibility that some areas of high-grade ma-

    lignant tumor were present from the onset. In addition to

    the patient with coexistent low-grade and high-grade surface

    osteosarcoma, slides were available for adequate sampling

    of the primary lesion in five patients. In the five remaining

    patients, the original histological material was not available

    for review and the historical information was not sufficient

    to confirm that there was no coexistent high-grade tumor at

    the time that the patient was originally treated. In these five

    patients, however, the intervals from the time of initial

    treatment to the time of dedifferentiation were ten, thirty-

    three, fifteen, ten, and fourteen years; if high-grade osteo-

    sarcoma had coexisted with the original lesions, recurrence

    would probably have been much earlier. Moreover, ade-

    quate sampling of the dedifferentiated tumor is generally

    not a problem because the dedifferentiated areas are grossly

    recognizable and different from the usual parosteal osteo-

    sarcoma. The usual low-grade parosteal osteosarcoma is

    densely ossified; in contrast, the areas of dedifferentiation

    are often softer and less densely ossified.

    The survival rate of patients with dedifferentiated par-

    osteal osteosarcoma has been worse than that of patients

    with the usual parosteal osteosarcoma. The prognosis for

    our patients appears to be similar to that for patients with

    high-grade intramedullary osteosarcoma . Medullary in-

    volvement does not appear to indicate a poorer prognosis.

    A variety of histologically different osteosarcomas can

    develop on the surface of bone. Because of differences in

    prognosis, these tumors should be considered distinct din-

    icopathological entities. As a group, parosteal osteosarco-

    mas can be associated with a good prognosis if the diagnosis

    is restricted to surface tumors that lack medullary involve-

    ment and that are histologically low-grade (Fig. 4). Simi-

    larly, periosteal osteosarcomas form a less common but

    equally distinct group with specific prognostic implications

    if the diagnosis is restricted to surface tumors that lack

    medullary involvement and that are lobulated and predom-

    inantly chondroblastic.

    High-grade osteosarcomas may involve the surface of

    bone in three ways. First, a typical intramedullary high-

    grade osteosarcoma may permeate the cortex and form a

    predominantly extra-osseous tumor. We believe that such a

    tumor should be considered an ordinary type of high-grade

    osteosarcoma. Second, on rare occasions a high-grade os-

    teosarcoma develops on the surface of a bone without med-

  • DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA 59

    ullary involvement. Such a tumor appears to have a forpatients with a usual parosteal osteosarcoma and appears

    prognosis similar to that of an ordinary intramedullary high- to be similar to that for patients with an intramedullary high-

    grade tumor. Finally, a high-grade osteosarcoma on the grade tumor. Therefore, not all surface osteosarcomas are

    surface of bone can coexist with or be a recurrence of a low-grade (stage-I) lesions. A proportion of them present

    usual parosteal osteosarcoma. This group ofdedifferentiated as high-grade tumors, and a significant number of low-grade

    parosteal osteosarcomas is the subject of this report. The lesions may dedifferentiate to become high-grade tumors

    prognosis for patients with these tumors is worse than that after inadequate excision.

    References

    I . BOWMAN, W. E. ,and Sist. F. H. : Limb Salvage in Primary Malignant Bone Tumors of the Pelvis. Orthop. Trans. , 7: 74, 1983.2. BRODERS, A. C.: Squamous-Cell Epithelioma of the Lip. A Study of Five Hundred and Thirty-seven Cases. J. Am. Med. Assn. . 74: 656-664.

    1920.

    3. DAHLIN. D. C.: Bone Tumors: General Aspects and Data on 3,987 Cases. Ed. 2, pp. 176-185. Springfield. Illinois. Charles C Thomas. 1967.4. DUNHAM. W. K. ; WII.B0RN. W. H. ; and ZARZOUR. R. J.: A Large Parosteal Osteosarcoma with Transformation to High-Grade Osteosarcoma.

    A Case Report. Cancer. 44: 1495-1500, 1979.5. DWINNELL, L. A. ; DAHLIN, D. C. ; and GHORMLEY. R. K. : Parosteal (Juxtacortical) Osteogenic Sarcoma. J. Bone and Joint Surg. ,36-A: 732-

    744. July 1954.6. ENNEKING, W. F. : SPANIER. S. S. ; and GOODMAN. M. A.: A System for the Surgical Staging of Musculoskeletal Sarcoma. Clin. Orthop. , 153:

    106-120, 1980.7. FARR, G. H., and Huvos, A. G.: Juxtacortical Osteogenic Sarcoma. An Analysis of Fourteen Cases. J. Bone and Joint Surg.. 54-A: 1205-12 16,

    Sept. 1972.8. GESCHICKTER, C. F., and COPELAND, M. M.: Parosteal Osteoma of Bone. A New Entity. Ann. Surg., 133: 790-806, 1951.9. LICHTENSTEIN, LOUIS: Tumors of Periosteal Origin. Cancer, 8: 1060-1069, 1955.

    10. SCAGLIETTI, 0. , and CALANDRIELLO. B. : Ossifying Parosteal Sarcoma. Parosteal Osteoma or Juxtacortical Osteogenic Sarcoma. J. Bone and JointSurg. , 44-A: 635-647, June 1962.

    1 1. SIM, F. H.; IviNs, J. C.; and PRITCHARD, D. J.: Surgical Treatment of Osteogenic Sarcoma at the Mayo Clinic. Cancer Treat. Rep., 62: 205-21 1,1978.

    12. UNNI. K. K.; DAHLIN. D. C.; BEABOUT. J. W.: and IvINs, J. C.: Parosteal Osteogenic Sarcoma. Cancer, 37: 2466-2475, 1976.13. UNNI. K. K.; DAHLIN, D. C.: MCLEOD, R. A.; and PRITCHARD, D. J.: Intraosseous Well-Differentiated Osteosarcoma. Cancer. 40: 1337-1347,

    1977.14. VAN DER HEUL. R. 0. , and VON RONNEN, J. R. : Juxtacortical Osteosarcoma. Diagnosis, Differential Diagnosis, Treatment, and an Analysis of

    Eighty Cases. J. Bone and Joint Surg. . 49-A: 415-439, April 1967.

    VOL. 66-A, NO. I. JANUARY 1984